ALKSHealthcare
Alkermes plc (ALKS) Insider Trading
In the last 90 days, 4 Alkermes plc (ALKS) insiders reported no open-market purchases and 7 sales totaling $3,752,026. Source: SEC Form 4 filings.
SEC-reported filing activity is provided for research purposes and is not investment advice.
- 90-day C-suite buyers
- 0
- 90-day purchase value
- $0.00
- Corporate buyers
- 0
- Latest transaction
- Oct 2, 2026
Executive filings
Open-market transaction history
Purchase and sale summaries are ordered by the latest reported transaction date.
Common questions
ALKS insider trading FAQ
- Are ALKS insiders buying or selling?
- Over the last 90 days, ALKS insiders were net sellers, reporting $0.00 of open-market purchases and $3,752,026 of sales.
- When was the last ALKS insider purchase?
- No open-market insider purchase of Alkermes plc stock was reported in the last 90 days.
- Where does ALKS insider trading data come from?
- Watch Insiders reads the SEC Form 4 filings that Alkermes plc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.
Healthcare
Related tickers with recent insider filings
- UTHR insider tradingUnited Therapeutics Corp69 filings
- TWST insider tradingTwist Bioscience Corp37 filings
- TEM insider tradingTempus AI Inc24 filings
- NTRA insider tradingNatera Inc22 filings
- CORT insider tradingCorcept Therapeutics Inc20 filings
- CSTL insider tradingCastle Biosciences Inc20 filings
- CLOV insider tradingClover Health Investments Corp18 filings
- MEDP insider tradingMedpace Holdings Inc18 filings
